Source · Select Committees · Public Accounts Committee
Recommendation 17
17
Government's 2019-24 AMR action plan progress lacks transparency and public accessibility.
Conclusion
The 2019–24 NAP’s commitments were tracked internally, and the government has not published information on its progress across all of its commitments.44 While some data on the 2019–24 NAP’s quantitative targets is available through publications by UKHSA and Defra, this information has not been brought together in one publication and is highly technical which may make it inaccessible to the lay reader.45 We received several written submissions which pointed to concerns about transparency on and accountability for the UK’s work on tackling AMR.46 This included a submission from the Microbiology Society which reported concern in the microbiology community that there was a lack of clarity on how the 2024–29 NAP will be implemented, how success will be measured and how government will be held accountable for its performance.47 38 Q 59 39 Qq 82–83; C&AG’s Report, para 3.6 40 Q 59 41 Q 36; C&AG’s Report, para 11 42 C&AG’s Report, paras 2.23–2.24 43 HM Government, Confronting antimicrobial resistance 2024 to 2029, May 2024 44 C&AG’s Report, para 2.24. 45 UKHSA, English surveillance programme for antimicrobial utilisation and resistance, 2023–24; Veterinary Medicines Directorate, UK Veterinary Antibiotic Resistance and Sales Report 2022 46 AR0004, AR0005, AR0006, AR0015, AR0024 47 AR0015 13
Government Response
A response document is linked to this report, dated 18 September 2025. Response attribution to this conclusion has not been verified. Read the response document ↗